05Sep 2023
Study Reveals Doxycycline May Help Reduce COPD Exacerbations in Specific Patient Group

Study Reveals Doxycycline May Help Reduce COPD Exacerbations in Specific Patient Group

A recent study examined the efficacy of doxycycline in 222 moderate to very severe COPD patients over 12 months. The study found that doxycycline reduced exacerbations, especially in patients with severe COPD and low eosinophil counts. However, it did not affect FEV1 and was associated with worsened health status. Gastrointestinal side effects were more familiar with doxycycline. The effectiveness of doxycycline may vary among COPD phenotypes and endotypes. Overall, this study suggests that doxycycline could benefit for specific COPD patients.

  • #critical care

Like

Save

Share